Q3 2024 · 13F-HR
NEA Management Company, LLCholdings as filed
Filed 2024-11-14 · accession 0001012975-24-000496
$1.84B
Reported value
42
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $312.8M | 17.0% | 3,745,262 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $304.8M | 16.6% | 5,385,979 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $160.7M | 8.75% | 5,584,753 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $152.5M | 8.31% | 2,909,956 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $103.8M | 5.65% | 24,471,264 | Common | SOLE |
| 22266M104 | COUR | COURSERA INC | $102.2M | 5.57% | 12,867,769 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $93.9M | 5.12% | 3,614,486 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $74.6M | 4.06% | 1,587,854 | Common | SOLE |
| 65345N106 | NN | NEXTNAV INC | $61.3M | 3.34% | 8,189,156 | Common | SOLE |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $44.2M | 2.41% | 2,613,948 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $40.8M | 2.22% | 7,692,298 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $38.0M | 2.07% | 11,370,376 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $36.5M | 1.99% | 1,090,793 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $35.4M | 1.93% | 1,960,169 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $29.1M | 1.59% | 3,969,834 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $20.9M | 1.14% | 2,370,542 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS INC | $19.4M | 1.05% | 4,448,757 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $18.6M | 1.02% | 1,250,001 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $17.9M | 0.98% | 18,093,034 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $16.2M | 0.88% | 17,079,778 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $16.1M | 0.88% | 3,568,781 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $15.4M | 0.84% | 1,500,000 | Common | SOLE |
| 10920V404 | — | NEUEHEALTH INC | $14.2M | 0.78% | 2,726,917 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $12.7M | 0.69% | 2,437,689 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $12.6M | 0.69% | 2,776,409 | Common | SOLE |
| 12430A300 | BZFD | BUZZFEED INC | $10.2M | 0.56% | 3,833,473 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $10.2M | 0.55% | 6,467,802 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $10.0M | 0.55% | 14,986,793 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $8.3M | 0.45% | 1,713,720 | Common | SOLE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $8.1M | 0.44% | 4,785,494 | Common | SOLE |
| 25058X303 | DM* | DESKTOP METAL INC | $6.7M | 0.37% | 1,439,892 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $5.5M | 0.30% | 2,000,275 | Common | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $4.4M | 0.24% | 2,922,772 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $4.0M | 0.22% | 6,147,260 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $3.7M | 0.20% | 2,382,286 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $3.0M | 0.16% | 1,071,428 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $2.7M | 0.15% | 1,462,586 | Common | SOLE |
| N01045207 | AFMDQ | AFFIMED NV | $1.5M | 0.08% | 442,648 | Common | SOLE |
| 45175G108 | — | IKENA ONCOLOGY INC | $1.0M | 0.06% | 600,063 | Common | SOLE |
| 81726A209 | — | SENTI BIOSCIENCES INC | $1.0M | 0.05% | 442,615 | Common | SOLE |
| 96328L205 | 2CH | WHEELS UP EXPERIENCE INC | $256,823 | 0.01% | 106,125 | Common | SOLE |
| 628988107 | MYND | MYND AI INC | $164,966 | 0.01% | 206,208 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.